Clinical Trial Detail

NCT ID NCT02477878
Title Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bellicum Pharmaceuticals
Indications

myelodysplastic syndrome

lymphoma

leukemia

multiple myeloma

Therapies

BPX-601

Rimiducid

Age Groups: adult

No variant requirements are available.